Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 455,472 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Sep 15, 2022, when has been sold 5,675 shares (ResMed Common Stock) at a price of $228.96 per share, resulting in proceeds of $1,299,348. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 455K

1.87% 3M change

3.84% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 15 2022	SELL Open market or private sale	$1,299,348 $228.96 p/Share	5,675 Reduced 1.33%	422,570 ResMed Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.31%	428,245 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	17,310 Added 3.94%	422,570 ResMed Common Stock
Aug 15 2022	SELL Open market or private sale	$1,351,161 $238.09 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Jul 15 2022	SELL Open market or private sale	$1,276,535 $224.94 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Jun 15 2022	SELL Open market or private sale	$1,149,414 $202.54 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
May 16 2022	SELL Open market or private sale	$1,115,762 $196.61 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Apr 18 2022	SELL Open market or private sale	$1,318,927 $232.41 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Mar 15 2022	SELL Open market or private sale	$1,375,450 $242.37 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Feb 15 2022	SELL Open market or private sale	$1,328,290 $234.06 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Jan 18 2022	SELL Open market or private sale	$1,373,010 $241.94 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Dec 15 2021	SELL Open market or private sale	$1,450,133 $255.53 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Nov 19 2021	SELL Bona fide gift	-	44,250 Reduced 9.84%	405,229 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	4,469 Added 0.98%	449,479 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$10,755,530 $254.81 p/Share	42,210 Reduced 8.66%	445,010 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$18,158,270 $254.81 p/Share	71,262 Added 12.76%	487,220 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF